Healthtech Startups
16,685 companies tagged Healthtech, with their investors and founders.
Altibbi is a digital health company offering telehealth and remote healthcare services, partnering with digital health organizations to serve healthcare program users. It provides telemedicine access aimed at improving the quality of remote care.
3 investors
Altitude provides a clinician-level execution platform that augments primary care providers' capabilities for managing chronic conditions using AI-native technology. The platform helps generalist clinicians deliver specialist-level care at scale, improving patient outcomes and care team efficiency.
3 investors
Altris AI develops artificial intelligence software for analyzing optical coherence tomography (OCT) scans in eye care, serving ophthalmologists and optometrists for diagnostic support and patient assessment. The company's platform helps detect retinal conditions and glaucoma risk, and is installed in over 500 optometry centers and clinics globally.
3 investors
AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease. Its programs are in preclinical through Phase II development.
3 investors
3 investors
AM-Pharma develops ilofotase alfa, a recombinant alkaline phosphatase enzyme therapy, and is studying it as a treatment for adults with hypophosphatasia (HPP), a rare inherited metabolic bone disease. The company focuses on addressing the unmet need of adult-onset HPP patients who lack disease-specific treatment options.
3 investors
Amalgam builds a modular, AI-powered Software as a Medical Device (SaMD) platform and EHR-integrated solutions for life sciences companies, health plans, and providers to support clinical decisions, patient engagement, and digital therapeutics. It also acts as Manufacturer of Record for regulated software, holding regulatory clearance across four continents.
3 investors
XRHealth provides telehealth therapy delivered at home using FDA-registered VR/AR headsets, mobile apps, wearables, and prescription digital therapeutics (such as Stanza), combined with licensed clinicians. It focuses on chronic pain and fibromyalgia, along with mental health, physical rehabilitation, and cognitive training, with programs covered by insurance in the United States.</parameter> <parameter name="hq_country">US
3 investors
The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
3 investors
Enabling telemedicine and digital health
3 investors
AMPLY Discovery is a UK-based biotech company that uses AI and computational biology to identify therapeutic targets in non-coding regions of the genome and develop first-in-class drugs through an integrated discovery platform combining machine learning with wet-lab validation. The company is developing therapeutics for oncology and drug-resistant infectious diseases, particularly antimicrobial-peptide and long non-coding RNA oligonucleotide programmes.
3 investors
Anagram builds software to help eye care providers manage vision insurance, lab ordering, and administrative workflows so they can deliver better patient care affordably.
3 investors
Ångström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.
3 investors
Anima is a healthcare platform that combines online consultation with productivity tools, featuring EHR integration, advanced analytics, and AI-powered document processing to streamline primary care workflows and improve patient outcomes.
3 investors
Anja Health provides cord blood banking and stem cell storage services from umbilical cords and placentas for families. The company aims to make stem cell preservation accessible and affordable for new parents.
3 investors
Annexon Bio develops early complement inhibitors that target C1q, the initiating molecule of the classical complement pathway, to treat autoimmune, neurodegenerative, and ophthalmic diseases. Its therapies aim to block complement-driven damage affecting the body, brain, and eye.
3 investors
Anonymous Health connects people in addiction recovery with care providers, supporting them through ongoing conversations and relationships. It operates in the digital health space with a focus on recovery and mental health support.
3 investors
Antag Therapeutics develops GIP receptor antagonist therapies for obesity, diabetes, and overweight patients. The company's lead candidate, AT-7687, is a clinical-stage peptide designed to block dysfunctional biological pathways contributing to fat storage and metabolic dysfunction, offering an alternative treatment approach with improved tolerability.
3 investors
A portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research from top universities into novel therapeutics. The company develops a diversified pipeline of drug candidates across multiple therapeutic areas, with partnerships spanning six leading UK research institutions.
3 investors
Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer. It operates as a publicly traded (Nasdaq-listed) drug developer with clinical programs including vebreltinib (APL-101).
3 investors
Append Medical develops a transcatheter system using vacuum-based technology to treat non-valvular atrial fibrillation by occluding the left atrial appendage without implanting a device in the heart. The system aims to reduce stroke risk in cardiac patients by eliminating device-related thromboembolism and peri-device leakage complications.
3 investors
APR is a South Korean beauty-tech company that develops and manufactures beauty devices (such as EMS, HIFU, and radio-frequency skincare devices under its Medicube AGE-R line) alongside cosmetics, fragrance, and fashion brands including APRILSKIN, Medicube, Forment, and NERDY. The company sells through its own direct-to-consumer online stores and operates internationally with subsidiaries across Asia and the US.
3 investors
Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability. It serves pharmacists, health plans, and Medicaid/Medicare programs, with tools addressing medication adherence, health equity, and quality metrics such as HEDIS and Stars.
3 investors
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing. It serves the swine veterinary and animal health industry.
3 investors